Sido Muncul PT
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through Herbal Medicine and Supplements, Food and Beverage, and Pharmacy segments. It also offers ethical and OTC products for various health interests, including ache and pain relief, antibiotics, anemia, anti-allergy, antioxidants, blood pressure,… Read more
Sido Muncul PT (SIDO) - Net Assets
Latest net assets as of December 2025: Rp3.12 Trillion IDR
Based on the latest financial reports, Sido Muncul PT (SIDO) has net assets worth Rp3.12 Trillion IDR as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp3.68 Trillion) and total liabilities (Rp561.44 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp3.12 Trillion |
| % of Total Assets | 84.75% |
| Annual Growth Rate | 19.73% |
| 5-Year Change | -10.1% |
| 10-Year Change | 13.15% |
| Growth Volatility | 45.39 |
Sido Muncul PT - Net Assets Trend (2009–2025)
This chart illustrates how Sido Muncul PT's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sido Muncul PT (2009–2025)
The table below shows the annual net assets of Sido Muncul PT from 2009 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Rp3.12 Trillion | -10.53% |
| 2024-12-31 | Rp3.49 Trillion | +3.01% |
| 2023-12-31 | Rp3.39 Trillion | -3.41% |
| 2022-12-31 | Rp3.51 Trillion | +0.99% |
| 2021-12-31 | Rp3.47 Trillion | +7.74% |
| 2020-12-31 | Rp3.22 Trillion | +5.12% |
| 2019-12-31 | Rp3.06 Trillion | +5.58% |
| 2018-12-31 | Rp2.90 Trillion | +0.23% |
| 2017-12-31 | Rp2.90 Trillion | +5.00% |
| 2016-12-31 | Rp2.76 Trillion | +6.14% |
| 2015-12-31 | Rp2.60 Trillion | -1.38% |
| 2014-12-31 | Rp2.63 Trillion | +0.35% |
| 2013-12-31 | Rp2.63 Trillion | +101.24% |
| 2012-12-31 | Rp1.30 Trillion | +143.70% |
| 2011-12-31 | Rp535.34 Billion | +54.54% |
| 2010-12-31 | Rp346.41 Billion | +98.05% |
| 2009-12-31 | Rp174.91 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sido Muncul PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 762.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp945.26 Billion | 30.29% |
| Common Stock | Rp1.50 Trillion | 48.07% |
| Other Comprehensive Income | Rp322.98 Billion | 10.35% |
| Other Components | Rp352.18 Billion | 11.29% |
| Total Equity | Rp3.12 Trillion | 100.00% |
Sido Muncul PT Competitors by Market Cap
The table below lists competitors of Sido Muncul PT ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nanjing Inform Storage Equip
SHG:603066
|
$192.61 Million |
|
Alector Inc
NASDAQ:ALEC
|
$192.67 Million |
|
Tianjin Guifaxiang 18th Street Mahua Food Co Ltd
SHE:002820
|
$192.71 Million |
|
Lanner Electronics
TWO:6245
|
$192.80 Million |
|
Chongqing Constr Engineering
SHG:600939
|
$192.58 Million |
|
Kepler Weber S.A
SA:KEPL3
|
$192.56 Million |
|
DRB - Hicom Bhd
KLSE:1619
|
$192.48 Million |
|
FB Bancorp, Inc. Common Stock
NASDAQ:FBLA
|
$192.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sido Muncul PT's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,487,837,000,000 to 3,120,427,000,000, a change of -367,410,000,000 (-10.5%).
- Net income of 1,229,202,000,000 contributed positively to equity growth.
- Dividend payments of 1,275,096,000,000 reduced retained earnings.
- Share repurchases of 299,615,000,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp1.23 Trillion | +39.39% |
| Dividends Paid | Rp1.28 Trillion | -40.86% |
| Share Repurchases | Rp299.62 Billion | -9.6% |
| Other Changes | Rp-21.90 Billion | -0.7% |
| Total Change | Rp- | -10.53% |
Book Value vs Market Value Analysis
This analysis compares Sido Muncul PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.86x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 44.50x to 4.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | Rp11.46 | Rp510.00 | x |
| 2011-12-31 | Rp17.71 | Rp510.00 | x |
| 2012-12-31 | Rp43.16 | Rp510.00 | x |
| 2013-12-31 | Rp86.85 | Rp510.00 | x |
| 2014-12-31 | Rp87.16 | Rp510.00 | x |
| 2015-12-31 | Rp86.36 | Rp510.00 | x |
| 2016-12-31 | Rp92.61 | Rp510.00 | x |
| 2017-12-31 | Rp96.55 | Rp510.00 | x |
| 2018-12-31 | Rp96.77 | Rp510.00 | x |
| 2019-12-31 | Rp102.17 | Rp510.00 | x |
| 2020-12-31 | Rp107.41 | Rp510.00 | x |
| 2021-12-31 | Rp116.38 | Rp510.00 | x |
| 2022-12-31 | Rp116.85 | Rp510.00 | x |
| 2023-12-31 | Rp112.86 | Rp510.00 | x |
| 2024-12-31 | Rp116.26 | Rp510.00 | x |
| 2025-12-31 | Rp104.99 | Rp510.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sido Muncul PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 39.39%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 30.13%
- • Asset Turnover: 1.11x
- • Equity Multiplier: 1.18x
- Recent ROE (39.39%) is above the historical average (30.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 68.47% | 12.71% | 2.10x | 2.57x | Rp202.53 Billion |
| 2011 | 63.50% | 15.46% | 1.88x | 2.18x | Rp286.40 Billion |
| 2012 | 29.70% | 16.20% | 1.11x | 1.65x | Rp257.07 Billion |
| 2013 | 15.46% | 17.11% | 0.80x | 1.12x | Rp143.40 Billion |
| 2014 | 15.76% | 18.89% | 0.78x | 1.07x | Rp151.73 Billion |
| 2015 | 16.84% | 19.72% | 0.79x | 1.08x | Rp177.64 Billion |
| 2016 | 17.42% | 18.76% | 0.86x | 1.08x | Rp204.74 Billion |
| 2017 | 18.43% | 20.74% | 0.81x | 1.09x | Rp244.21 Billion |
| 2018 | 22.87% | 24.02% | 0.83x | 1.15x | Rp373.59 Billion |
| 2019 | 26.35% | 26.33% | 0.87x | 1.15x | Rp501.22 Billion |
| 2020 | 28.99% | 28.00% | 0.87x | 1.19x | Rp611.84 Billion |
| 2021 | 36.32% | 31.36% | 0.99x | 1.17x | Rp913.78 Billion |
| 2022 | 31.51% | 28.58% | 0.95x | 1.16x | Rp754.17 Billion |
| 2023 | 28.08% | 26.66% | 0.92x | 1.15x | Rp612.05 Billion |
| 2024 | 33.57% | 29.88% | 0.99x | 1.13x | Rp822.24 Billion |
| 2025 | 39.39% | 30.13% | 1.11x | 1.18x | Rp917.16 Billion |
Industry Comparison
This section compares Sido Muncul PT's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $915,806,856,065
- Average return on equity (ROE) among peers: 19.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sido Muncul PT (SIDO) | Rp3.12 Trillion | 68.47% | 0.18x | $192.60 Million |
| Darya-Varia Laboratoria Tbk (DVLA) | $1.20 Trillion | 16.72% | 0.40x | $8.73 Million |
| Indofarma Tbk (INAF) | $292.57 Billion | 37.70% | 0.84x | $4.64 Million |
| Merck Tbk (MERK) | $416.74 Billion | 25.87% | 0.37x | $11.43 Million |
| Phapros Tbk PT (PEHA) | $821.61 Billion | 12.42% | 1.55x | $4.70 Million |
| Pyridam Farma Tbk (PYFA) | $118.93 Billion | 7.10% | 0.57x | $76.03 Million |
| Tempo Scan Pacific Tbk (TSPC) | $2.64 Trillion | 18.49% | 0.36x | $70.32 Million |